Binding of ouabain to Na
By specific binding to the extracellular surface of the ␣-subunit of Na ϩ /K ϩ -ATPase, cardiotonic steroids such as ouabain inhibit the ion pumping function of the enzyme. In recent years, we have demonstrated that the binding of ouabain to cardiac Na ϩ /K ϩ -ATPase can also activate multiple signal transduction pathways including activation of Ras and p42/44 MAPKs 1 and increased production of reactive oxygen species (4 -8) . Interestingly, the activation of some of the signal transduction pathways by ouabain is independent of the ouabain-induced changes in intracellular ion concentrations as well as the contractility of cardiac myocytes (9, 10) . Significantly, we have recently shown that the classic effects of ouabain on intracellular calcium also depend on the signal transducing function of Na ϩ /K ϩ -ATPase (11) . Inhibition of either protein tyrosine phosphorylation or Ras/p42/44 MAPKs diminishes ouabaininduced increases in intracellular calcium. Furthermore, interplays among different pathways (e.g. MAPKs, calcium, and reactive oxygen species) in cardiac myocytes eventually lead to hypertrophic growth and changes in the expression of multiple growth-related genes (4) .
Because there is sufficient evidence that activation of the Ras/MAPKs is important for regulating cell function and growth, we have recently initiated studies to explore the upstream signaling events that emanate from the binding of ouabain to Na ϩ /K ϩ -ATPase. Traditionally, binding of the growth factor to its receptor results in receptor dimerization and autophosphorylation (12, 13). The tyrosine-phosphorylated receptor can then serve as a scaffold to recruit Src and adaptor proteins, resulting in activation of the Ras/MAPK cascade. More recently, the EGFR and Src have been identified as critical elements that relay the signals from G protein-coupled receptors, cytokines, and cellular stress to a variety of cellular responses, which include the activation of MAPKs (14 -19) . Our previous work demonstrated that ouabain caused a rapid activation of Src and stimulated tyrosine phosphorylation of the EGFR in both cardiac myocytes and A7r5 cells (9) . Furthermore, inhibition of tyrosine kinases by either genistein or herbimycin A antagonized the effects of ouabain on MAPKs. These findings led us to postulate that the activation of Src by ouabain was sufficient to transactivate the EGFR, resulting in the recruitment of Shc and Grb2 to the receptor and subsequent activation of the Ras/MAPK cascade (9) . The present studies were performed to test this hypothesis and delineate the molecular mechanisms of ouabain-induced activation of Src and transactivation of the EGFR.
EXPERIMENTAL PROCEDURES
Materials-Chemicals of the highest purity were used. Herbimycin A, PP2, tyrphostin AG1295, and tyrphostin AG1478 were obtained from Calbiochem. Sodium binding benzofuran isophthalate acetoxymethyl ester was from Molecular Probes (Eugene, OR). [␥- 32 P]ATP was obtained from PerkinElmer Life Sciences. The following antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA): monoclonal anti-phosphotyrosine antibody (PY99), polyclonal anti-MAPK antibody, monoclonal anti-phospho-MAPK antibody, and goat anti-rabbit and goat anti-mouse secondary antibodies. The following antibodies and kits were obtained from Upstate Biotechnology (Lake Placid, NY): monoclonal anti-Src (clone GD11), anti-Ras (clone RAS10), anti-Grb2, and anti-phospho-EGFR (Tyr 1173 ) (clone 9H2) antibodies, polyclonal anti-Shc and anti-EGFR antibodies, Src kinase activity and Ras activation kits, and protein G-agarose. The polyclonal anti-Src (pY 418 ) and anti-Src (pY 529 ) antibodies were from BIOSOURCE. The monoclonal anti-␣ 1 antibody (␣6F) was obtained from the Developmental Studies Hybridoma Bank at the University of Iowa (Iowa City, IA). The Optitran nitrocellulose membranes used for Western blotting were obtained from Schleicher and Schuell.
Cell Preparation and Culture-Rat A7r5, pig LLC-PK1, and mouse SYF and SYF ϩ c-Src cells were obtained from American Type Culture Collection and cultured in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, penicillin (100 units/ml), and streptomycin (100 g/ml). When cell cultures reached about 80% confluence, A7r5 and LLC-PK1 cells were serum-starved for 24 h and used for the experiments, whereas SYF and SYF ϩ c-Src cells were cultured in medium containing 0.5% fetal bovine serum for 24 h before being used for the experiments.
Measurement of Protein Tyrosine Phosphorylation and p42/44 MAPK Activity-Immunoblotting was performed to identify increases in tyrosine phosphorylation and activation of p42/44 MAPK using the antibodies described under "Materials" (9) . Dilutions of these antibodies were done as recommended by the manufacturer. After the indicated treatment, the incubation medium was rapidly replaced with 5 ml of ice-cold phosphate-buffered saline. The washed cells were then lysed in 200 l of ice-cold RIPA containing 1% Nonidet P-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium orthovanadate, 1 mM NaF, 10 g/ml aprotinin, 10 g/ml leupeptin, and 50 mM Tris-HCl (pH 7.4). Cell lysates were centrifuged at 16,000 ϫ g for 10 min, and the supernatants were used for Western blot analysis. Samples were separated by SDS-PAGE (60 g/ lane) and transferred to an Optitran membrane as described previously (9) . The membranes were then probed with an anti-phosphotyrosine monoclonal antibody or an anti-phospho-MAPK monoclonal antibody. The anti-phospho-MAPK monoclonal antibody was then stripped, and the membrane was reprobed with a polyclonal antibody that recognizes the total amount of MAPK to account for equal loading as reported previously (9) . Autoradiograms were scanned with a Bio-Rad densitometer to quantitate MAPK signals as described previously (9) .
Assay for Src Kinase Activity-To assay Src kinase activity, cells were lysed in RIPA at 4°C. The insoluble material was removed by centrifugation at 16,000 ϫ g for 10 min, and the cell lysates were immunoprecipitated using the Src monoclonal antibody and protein G-agarose. The immunoprecipitate was washed twice with RIPA and twice with ice-cold phosphate-buffered saline. Src kinase activity was assayed as described previously (9) .
Assay for EGFR Tyrosine Phosphorylation and Src, Shc, and Grb2 Association-Cell lysates made in RIPA were immunoprecipitated using a polyclonal anti-EGFR antibody that has established reactivity with the rat receptor. The immunoprecipitate was dissolved in sample buffer, separated on 10% SDS-PAGE, and blotted with the monoclonal anti-phosphotyrosine antibody. To determine whether EGFR binds to Src, Shc, and Grb2, the same blots were stripped and reprobed with the monoclonal anti-Src antibody, the polyclonal anti-Shc antibody, and the monoclonal anti-Grb2 antibody. To determine whether the EGFR is autophosphorylated at its major phosphorylation site (Tyr 1173 ), the lysates made in RIPA were immunoprecipitated using a polyclonal anti-EGFR antibody. The immunoprecipitate was dissolved in SDS sample buffer, separated by 10% SDS-PAGE, and blotted with a monoclonal anti-phospho-EGFR antibody raised against peptide NA-E[pY]LRV that corresponds to the protein sequence around Tyr 1173 of the EGFR.
Assay for Src Binding to Na ϩ /K ϩ -ATPase-RIPA cell lysates were immunoprecipitated with either a polyclonal anti-␣ 1 antibody or a monoclonal anti-Src antibody as described in the preceding paragraph.
Immunoprecipitates were then separated by SDS-PAGE and immunoblotted for ␣ 1 and Src.
Assay for Ras Activation-To assay for Ras activation, cells were collected in a Mg 2ϩ -containing lysis buffer (MLB) containing 150 mM NaCl, 1% Igepal CA-630, 0.25% sodium deoxycholate, 10% glycerol, 25 mM NaF, 10 mM MgCl 2 , 1 mM EDTA, 1 mM sodium orthovanadate, 10 g/ml aprotinin, 10 g/ml leupeptin, and 25 mM HEPES (pH 7.5). Active Ras was then affinity-precipitated by adding 20 l of the Raf-1 Ras binding domain-agarose conjugate to the cell lysates and gently rocking them for 30 min at 4°C. The agarose beads were washed three times with MLB, dissolved in 50 l of 2ϫ SDS sample buffer, and boiled for 5 min. The samples were separated by 10% SDS-PAGE, transferred to a supported nitrocellulose membrane, and blotted with a monoclonal anti-Ras antibody.
Assay for Na ϩ /K ϩ -ATPase Activity and Intracellular Na ϩ Concentration-Whole cell total Na ϩ /K ϩ -ATPase activity was assayed in the presence of alamethicin as described previously (20) . Briefly, cells were collected from the cultures and treated with alamethicin at a concentration of 0.1 mg/mg protein. Na ϩ /K ϩ -ATPase activity was measured by the determination of the initial rate of release of P i from ATP. The reaction was carried out in a final volume of 1 ml of reaction mixture containing 100 mM NaCl, 20 mM KCl, 3 mM MgCl 2 , 1 mM EGTA, 5 mM NaN 3 , and 2 mM [␥-32 P]ATP. To determine the ouabain concentration curves, whole cell lysates were preincubated with different concentrations of ouabain for 15 min. The reaction was started by the addition of an aliquot of cell lysate (50 g). Intracellular Na ϩ concentration was measured using sodium binding benzofuran isophthalate as a probe as described previously (10) .
Analysis of Data-Data are given as the mean Ϯ SE. Statistical analysis was performed using Student's t test, and significance was accepted at p Ͻ 0.05. Each presented immunoblot is representative of the similar results of at least three separate experiments.
RESULTS

The Dose-dependent Effects of Ouabain on Src and MAPKs
Correlate with the Ouabain Sensitivities of the Cells-We have shown previously that ouabain activates Src and increases tyrosine phosphorylation of the EGFR in several cell types (9) . Although it is well established that Na ϩ /K ϩ -ATPase is the specific receptor for cardiotonic steroids such as ouabain, it is always possible that some of the novel effects of ouabain may be due to its binding to other cellular proteins, especially at higher ouabain concentrations. To address this issue, we compared the dose-dependent effects of ouabain on Na ϩ /K ϩ -ATPase activity and MAPK activation. When Na ϩ /K ϩ -ATPase activity was measured in A7r5 and LLC-PK1 cells as a function of ouabain concentration, it is clear that LLC-PK1 cells express a highly ouabain-sensitive isoform of Na ϩ /K ϩ -ATPase (Fig. 1) . The en- Interactions among Na ϩ /K ϩ -ATPase, Src, and EGFRzyme was inhibited 50% in LLC-PK1 cells when the cells were exposed to about 1 M ouabain. In contrast, 100 M ouabain was required to cause the same degree of inhibition of Na ϩ /K ϩ -ATPase activity in A7r5 cells. Interestingly, when Src and MAPKs were measured in these cells as a function of ouabain concentration, we found that the effects of ouabain on both MAPKs and Src correlated well with the inhibition curves of ouabain on Na ϩ /K ϩ -ATPase in these cells (Figs. 2 and 3). To ensure that ouabain-induced activation of MAPKs and Src is not a result of significant changes in intracellular Na ϩ or depolarization of the membrane potential due to inhibition of the ion pumping function of Na ϩ /K ϩ -ATPase, we measured the effects of ouabain on intracellular Na ϩ as a function of time in A7r5 cells loaded with sodium binding benzofuran isophthalate. Consistent with our prior studies (10), exposure of A7r5 cells to 100 M ouabain for 20 min did not change the intracellular Na ϩ concentration (17.1 Ϯ 1.2 versus 17.2 Ϯ 1.3 mM). Therefore, it is unlikely that the effects of ouabain on MAPKs are due to changes in either intracellular Na ϩ or membrane potential. This notion is further supported by the following observations. First, although the addition of monensin caused a large increase in intracellular Na ϩ , it failed to activate MAPKs (99.7 Ϯ 9.6% of control; n ϭ 3). Second, increasing extracellular K ϩ from 5 to 20 mM, which should cause partial depolarization of the plasma membrane, also showed no significant effect on MAPKs (114.8 Ϯ 5.4% of control; n ϭ 3).
Both Src and EGFR Are Required for Ouabain-induced Activation of MAPK-We showed that inhibition of protein tyrosine kinases by a nonspecific tyrosine kinase inhibitor (genistein) or a relatively selective Src inhibitor (herbimycin A) abolished ouabain-induced stimulation of p42/44 MAPKs (9) . To obtain additional evidence that Src is involved in ouabaininduced activation of MAPKs, A7r5 cells were pretreated with another Src-specific inhibitor, PP2, and then exposed to 100 M ouabain and assayed for MAPK activation. As depicted in Because receptor tyrosine kinases are involved in transmitting signals from H 2 O 2 and angiotensin II to MAPKs, the effects of either AG1478 or AG1295 on ouabain-induced activation of MAPKs were studied in the experiments of Fig. 6 . Both AG1478 and AG1295 belong to the tyrphostin family of receptor tyrosine kinase inhibitors. They are ATP analogues and specific toward the ATP binding sites of receptor tyrosine kinases. The selectivity and dose-dependent effects of these inhibitors on MAPK activation induced by either EGF or PDGF had been assessed previously in rat vascular smooth muscle cells (25) . These studies showed that AG1478 completely blocked the effects of EGF (50 ng/ml) on MAPKs at 250 nM, whereas AG1295 abolished the effects of PDGF (30 ng/ml) at 25 M. Control experiments showed that both AG1478 (250 nM) and AG1295 (25 M) had no effect on cell morphology and viability (assessed by trypan blue exclusion) when A7r5 cells were exposed to them for 1 h. Therefore, A7r5 cells were exposed to either 250 nM AG1478 or 25 M AG1295 and then treated with 100 M ouabain. Interestingly, whereas AG1478 blocked the effects of both EGF and ouabain on MAPKs (Fig. 6) , AG1295 inhibited the effects of PDGF but not ouabain on MAPKs. To ensure that the effects of AG1478 on ouabaininduced activation of MAPKs are specifically mediated through inhibition of the EGFR, the effects of 10 nM AG1478 on MAPK activation were also assessed. Previous studies on rat vascular smooth muscle cells indicated that 10 nM AG1478 caused about 50% inhibition of EGF-induced MAPK activation (25) . We found that AG1478 at the same concentration inhibited about 37% of both EGF-and ouabain-induced activation of MAPKs. Taken together, the above findings indicate that ouabain signals differently than both EGF and PDGF and demonstrate an involvement of the EGFR, but not the PDGFR, in ouabaininduced activation of MAPKs.
Ouabain Fig. 8 , we immunoprecipitated either ␣ 1 or Src from both control and ouabain-treated LLC-PK1 cells. LLC-PK1 cells were chosen for the immunoprecipitations because these cells express high levels of ouabain-sensitive Na ϩ /K ϩ -ATPase. Initial experiments with A7r5 cells proved to be difficult because each immunoprecipitation needed more than 2 mg of cell lysates to give a detectable signal of ␣ 1 by Western blot. As shown in Figs. 8 and 9, ouabain increased Src binding to Na ϩ /K ϩ -ATPase in a doseand time-dependent manner. The maximal effects of ouabain on Src binding were observed after the cells were incubated with ouabain for 2-5 min and decreased thereafter.
Inhibition of Src Blocks Ouabain-induced Src Binding to and Tyrosine Phosphorylation of the EGFR-Because
Src can mediate inter-receptor communications, the above findings prompted us to hypothesize that the Src-mediated inter-receptor cross-talk between Na ϩ /K ϩ -ATPase and the EGFR is essential for ouabain-induced activation of MAPKs. To test this hypothesis, we assessed the role of Src in ouabain-induced transactivation of the EGFR. In the experiments of Fig. 10 , A7r5 cells were pretreated with herbimycin A for 30 min and then exposed to either 100 M ouabain or 50 ng/ml EGF for 5 
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ϩ /K ϩ -ATPase, Src, and EGFRmin. After cells lysates were cleared by centrifugation and immunoprecipitated with an anti-EGFR antibody, immunoprecipitates were resolved by SDS-PAGE and probed for protein tyrosine phosphorylation and Src. As reported previously (9), ouabain increased Src binding to the EGFR and stimulated tyrosine phosphorylation of the receptor (Fig. 10) . EGF also increased tyrosine phosphorylation of the receptor and increased Src binding to the receptor. However, preincubation with herbimycin A diminished the above-mentioned effects of ouabain, but not EGF, on the EGFR (Fig. 10 ). In addition, preincubation of A7r5 cells with another Src inhibitor, PP2, also blocked Src binding to the EGFR and increased tyrosine phosphorylation of the receptor in response to ouabain (data not shown). Consistent with these findings and those of Fig. 5 , we found that ouabain stimulated tyrosine phosphorylation of the EGFR in SYF ϩ c-Src cells, but not in SYF cells (Fig. 11) . In contrast, EGF stimulated the receptor in both cells (Fig. 11) . Taken together, these findings support the notion that binding of ouabain to Na ϩ /K ϩ -ATPase activates Src kinase, which in turn increases its association with the EGFR and subsequently transactivates the receptor.
After binding to its cognate ligand, the EGFR monomers dimerize, resulting in activation of tyrosine kinase activity and trans-(auto)-phosphorylation of the receptor at the multiple tyrosine residues in the carboxyl-terminal tail. We showed previously by Western blot analysis of cell lysates that ouabain increased tyrosine phosphorylation of the EGFR at sites other than the major autophosphorylation site (Tyr 1173 ). Because the experiments in Fig. 6 indicated that EGFR tyrosine kinase activity was required for ouabain-induced activation of MAPKs, we reasoned that Western blot analysis of the cell lysates might not be sensitive enough to detect modest increases in phosphorylation of Tyr 1173 . Therefore, we re-examined the issue of whether ouabain stimulates tyrosine phosphorylation of the EGFR at Tyr 1173 by first immunoprecipitating the EGFR from the cell lysates and then probing for Tyr 1173 phosphorylation. As depicted in Fig. 12 , ouabain had no effect on the phosphorylation of Tyr 1173 , whereas EGF did (Fig. 12) .
Clearly, as reported previously (9), the ouabain-induced phosphorylation of the EGFR seen in Fig. 10 is likely at a site or sites other than Tyr 1173 . Interactions among Na ϩ /K ϩ -ATPase, Src, and EGFRwith EGF stimulation. Therefore, we assessed whether ouabain increased the binding of Shc to the activated EGFR. As in the experiments of Fig. 10 , anti-EGFR immunoprecipitates were resolved by SDS-PAGE and blotted with either an antiShc or an anti-phosphotyrosine antibody. EGF was again used as a positive control in these experiments. As depicted in Fig.  13A , both ouabain and EGF increased the association of Shc to the EGFR. Interestingly, although all three isoforms of Shc are expressed in A7r5 cells, ouabain increased the binding of p46 Shc and p52 Shc , but not p66 Shc , to the EGFR. In addition, because binding of Shc to the activated EGFR can stimulate Shc tyrosine phosphorylation, thus serving as binding sites for other adaptor proteins such as Grb2, we measured the effects of ouabain on tyrosine phosphorylation of Shc in A7r5 cells. We found that ouabain increased tyrosine phosphorylation of p52 Shc (Fig. 13B ) and p46 Shc , but not p66 Shc (data not shown), in A7r5 cells. As expected, pretreating A7r5 cells with the Src inhibitor PP2 blocked ouabain-induced increases in Shc phosphorylation (Fig. 13B) . Interestingly, inhibition of the EGFR by AG1478 also abolished the effects of ouabain on Shc tyrosine phosphorylation. These findings indicate that the Src-transactivated EGFR is capable of recruiting and phosphorylating Shc in response to ouabain. Because binding of Grb2/Sos to the transactivated EGFR is important for the subsequent recruitment and activation of Ras, we performed the experiments of Fig. 13A , showing that ouabain did indeed cause a significant increase in Grb2 binding to the transactivated EGFR-Shc complex.
Activation of the EGFR Is Sufficient for the Recruitment of Adaptor Proteins and Activation of Ras in Response to
To further investigate the signaling cascade following the binding of Shc and Grb2 to the EGFR, the effects of ouabain on Ras and Ras binding to Raf were also measured. Active or GTP-bound Ras was first affinity-precipitated from A7r5 cell lysates using the glutathione S-transferase-fused Ras-binding domain of Raf after treatment with either ouabain or EGF. The amount of Raf-bound Ras, or active Ras, was then determined by using an anti-Ras antibody. In cells treated with either ouabain or EGF, there was approximately a 3.5-and 10-fold increase in Ras binding to Raf, respectively (Fig. 14) . These findings indicated that ouabain activated Ras and increased 
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Ras binding to Raf. Clearly, the formation of a Src-EGFR complex in response to ouabain is sufficient to recruit other proteins to the plasma membrane, which results in the activation of the Ras/MAPK cascade. DISCUSSION Na ϩ /K ϩ -ATPase is well known for its essential function in maintaining the Na ϩ and K ϩ ion concentrations across the plasma membrane in most mammalian cells. Cardiac glycosides such as ouabain are known to bind to plasma membrane Na ϩ /K ϩ -ATPase and inhibit its ion transporting ability (1-3). Previously, we have shown that ouabain binding to Na ϩ /K ϩ -ATPase not only inhibits the ion pumping function of the enzyme but also converts the enzyme to a signal transducer. Subsequently, this results in the activation of several signaling cascades that ultimately lead to changes in the expression of multiple genes (4 -10) . In the present study, we have elucidated the mechanisms by which ouabain-bound Na ϩ /K ϩ -ATPase uses tyrosine kinases to assemble a membrane-associated protein complex for the regulation of the Ras/MAPK cascade in A7r5 and LLC-PK1 cells.
Interaction of Ouabain with Na ϩ /K ϩ -ATPase Initiates the Signal Transducing Function of the Enzyme-The earlier work in our laboratory focusing on MAPK and Src activation in response to ouabain was done in both neonatal cardiac myocytes and A7r5 cells (7) (8) (9) . These cells as well as mouse SYF ϩ c-Src cells are known to express a relatively ouabain-insensitive Na ϩ /K ϩ -ATPase ( Fig. 1 ; Ref. 20) , and significant stimulation of MAPKs occurs when 10 -20% of the enzyme is inhibited by ouabain. Although the effects of ouabain on MAPKs correlate well with its binding to Na ϩ /K ϩ -ATPase in these cells, there is always a possibility that 10 -100 M ouabain may affect other cellular proteins in addition to Na ϩ /K ϩ -ATPase. As shown in Fig. 1 , LLC-PK1 cells express a highly ouabainsensitive Na ϩ /K ϩ -ATPase ␣ 1 isoform. Fifty percent inhibition of the enzyme activity was observed when the cells were treated with 1 M ouabain. Concomitantly, these cells showed a high sensitivity to ouabain with respect to MAPK activation. Significant stimulation of MAPKs was observed when LLC-PK1 cells were exposed to 100 nM ouabain that bound to and inhibited about 20% of the enzyme in these cells (Figs. 1 and 2 ). In addition, when Src kinase activity was measured, 1 M ouabain caused the same degree of stimulation of Src kinase in LLC-PK1 cells as that induced by 100 M ouabain in A7r5 cells (Fig. 3) . Furthermore, our previous work also demonstrated that ouabain-induced increases in reactive oxygen species production in HeLa cells and rat cardiac myocytes correlated well with the ouabain sensitivities of the ␣ 1 isoforms expressed in these cells (10) . It was also reported that in canine smooth muscle cells, MAPKs were activated by 1 nM ouabain that would bind to about 5% of the enzyme in these cells (21) . Clearly, the signal transducing effects of ouabain are indeed due to its interaction with Na ϩ /K ϩ -ATPase.
Activation of Src by Ouabain Leads to the Transactivation of the EGFR and Assembly of the Proteins Involved in the Regulation of
MAPKs-Receptor tyrosine kinases are central elements for cellular signal transduction. Binding of a ligand to its receptor induces the formation of either homo-or heterodimers that subsequently trigger the autophosphorylation of cytoplasmic tyrosine residues of the receptor. These phosphorylated amino acid residues then function as docking sites for a variety of adaptor proteins that regulate membrane-proximal events of a signaling network, ultimately defining the biological response to a given signal (12). In recent years, there has been a growing body of evidence that receptor tyrosine kinases such as EGFR and PDGFR cross-communicate with other signaling systems to integrate the variety of extracellular stimuli into a limited number of signaling pathways. The activated EGFR, for example, has been identified as a critical element in the signal transduction networks of cytokines, H 2 O 2 , and those using G protein-coupled receptors (14 -19) . To distinguish this 
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ϩ /K ϩ -ATPase, Src, and EGFRnonclassical mode of stimulation from receptor activation by its cognate ligands, this process has been termed "EGFR transactivation" (14) . We previously demonstrated that binding of ouabain to Na ϩ /K ϩ -ATPase stimulated Src kinase activity and transactivated the EGFR. These findings prompted us to test whether the EGFR cross-talks to ouabain-bound Na ϩ /K ϩ -ATPase, resulting in activation of multiple downstream signaling processes. In the experiments of Figs. 4 and 6 , where the cells were pretreated with different tyrosine kinase inhibitors, we showed that inhibition of the EGFR abrogated the effects of ouabain on MAPKs. Interestingly, the EGFR was also shown to be involved in ouabain-induced activation of MAPKs in canine smooth muscle cells (21) . These findings convincingly demonstrated a cross-talk between Na ϩ /K ϩ -ATPase and the EGFR and identified the EGFR as a potential molecular scaffold for the assembly of a membrane-associated signaling complex for regulation of MAPKs. Because the PDGFR can also be transactivated by a variety of stimuli (22) , AG1295, a specific inhibitor of PDGFR, was used in the experiments of Fig. 6 to test its role in ouabain-induced activation of MAPKs. The results showed that AG1295 blocked PDGF-induced but not ouabaininduced activation of MAPKs. Thus, it is unlikely that the PDGFR plays a role in ouabain-induced activation of MAPKs. Furthermore, the findings of the experiments of Figs. 13 and 14 confirmed that the activated EGFR could function as a molecular scaffold to recruit and assemble a signaling complex on the cell membrane in response to ouabain stimulation because of the following observations. First, the tyrosine-phosphorylated EGFR was able to recruit both p46
Shc and p52 Shc , but not p66
Shc , in response to ouabain (Fig. 13A) . This is consistent with the notion that both p46
Shc and p52 Shc , but not p66 Shc , are involved in transmitting growth signals from receptor tyrosine kinases to downstream effectors such as MAPKs (14) . Significantly, AG1478 suppressed ouabain-induced tyrosine phosphorylation of Shc (Fig. 13B ), indicating that a functional EGFR is required for binding and phosphorylating Shc in response to ouabain. Because tyrosine phosphorylation of Shc is considered a critical step for the subsequent activation of the Ras/MAPK cascade (12-14), these findings are consistent with those of Fig.  6 showing that AG1478 blocked ouabain-induced activation of MAPKs. Second, after the stimulation of Shc tyrosine phosphorylation, ouabain increased the binding of the Grb2-Sos complex to the activated EGFR (Fig. 13A ). This resulted in the recruitment of Ras and the subsequent activation of the Raf/ MEK/MAPK cascade in A7r5 cells (Fig. 14) . Clearly, ouabain stimulates MAPK activity in A7r5 cells via the transactivated EGFR.
At least two distinct mechanisms have been revealed for the transactivation of the EGFR by stimuli other than its cognate ligand. One of them involves the increased release of the EGFR ligand heparin-binding EGF (14) . For example, stimulation of G-protein-coupled receptors by thrombin induces the proteolytic processing of the pro-heparin-binding EGF, and inhibition of either protease activity or heparin-binding EGF significantly reduces the stimulus-induced EGFR transactivation (14) . The other mechanism involves Src kinases in which stimulation of Src increases its binding to the EGFR and subsequent tyrosine phosphorylation of the receptor (14) . Furthermore, the Srcmediated tyrosine phosphorylation occurs at sites (Tyr 845 and Tyr 1101 ) other than those induced by autophosphorylation of the receptor upon binding its cognate ligand (23) . Such Srcmediated EGFR transactivation has been observed in different types of cells stimulated by either angiotensin II or H 2 O 2 (17) (18) (19) . In the experiments of Figs. 4 and 5, we showed that activation of Src was essential for ouabain-induced activation of MAPKs. We further demonstrated that inhibition of Src by both herbimycin A and PP2 completely blocked ouabain-induced but not EGF-induced Src association to the EGFR (Fig.  10) . These inhibitors also abolished ouabain-induced but not EGF-induced tyrosine phosphorylation of the EGFR (Fig. 10) . In addition, ouabain stimulated tyrosine phosphorylation of the EGFR in SYF ϩ c-Src cells, but not in SYF cells. These findings support the proposal that ouabain is most likely to transactivate the EGFR by increasing the association of the activated Src to the receptor. Furthermore, because ouabain acted differently than EGF in the regulation of MAPKs (Fig. 4) and failed to stimulate autophosphorylation of Tyr 1173 of the EGFR (Fig. 12; Ref. 9) , it is unlikely that increases in heparinbinding EGF release play an important role in the activation of the EGFR in response to ouabain in A7r5 cells. Taken together, the new findings support the proposal that the activation of Src is the initial critical step that relays the signal emanated from the interaction of ouabain with Na ϩ /K ϩ -ATPase to the EGFR. However, the molecular mechanisms by which ouabain-activated Src transactivates the EGFR remain to be resolved.
Can the Ouabain-Na ϩ /K ϩ -ATPase Complex Function as a Molecular Scaffold for Assembly of Signaling Complexes?-The assembly of a signaling module is essential for efficient and specific transmission of a signal from the receptor to the downstream effector (24) . Because the new findings above indicate that ouabain-bound Na ϩ /K ϩ -ATPase cross-communicates with the EGFR through activated Src, we are tempted to speculate that a pool of Na ϩ /K ϩ -ATPase is compartmentalized to a specific membrane domain that is enriched with multiple signaling proteins. The binding of ouabain to Na ϩ /K ϩ -ATPase increases the interaction of the enzyme with several proteins and brings them together so that the activated Src can transactivate the EGFR (24) . This hypothesis appears to be supported by the findings of Figs. 7 and 9. It is well established that Src kinase activity can be regulated by two different mechanisms. Activation of Src by angiotensin II is likely due to stimulation of a phosphotyrosine phosphatase because it decreases Src phosphorylation at Tyr 529 (25) . On the other hand, many stimuli can increase the competitive binding of a regulatory protein to either the SH2, SH3, or kinase domain of Src, resulting in increased phosphorylation at Tyr 418 and a subsequent increase in kinase activity (13, 17) . Because ouabain stimulated Src phosphorylation at Tyr 418 without affecting Tyr 529 phosphorylation (Fig. 7) , it is likely that the ouabain-induced Src activation is due to the increased interaction between Na (Figs. 8 and 9) . Interestingly, the ␣ 1 subunit of Na ϩ /K ϩ -ATPase contains a conserved functional proline-rich domain that has been shown to interact with the SH3 domain of phosphatidylinositol 3-kinase upon dopamine stimulation (26) . Therefore, we suggest that ouabain may increase the interaction of Na 
